iNDX.Ai ^Companies

iNDX.Ai is an organization that aims to accelerate translational research in the field of cancer by providing an AI-enabled biomarker discovery platform. Their comprehensive data analytics platform integrates an ecosystem to accelerate biomarker-based clinical trials. With a focus on modern, scalable, and secure solutions, iNDX.Ai ensures high security with advanced encryption and easy integration through an open API. Their services include automated primary and secondary analysis, saving costs on data management and analysis, identifying biomarker signatures, finding the right patients for trials, and improving the final clinical trial outcome. With a user-friendly visual experience, iNDX.Ai offers a revolutionary informatics platform for managing data-intensive and biomarker-rich precision medicine clinical trials.